Marrone Bio Innovations announces proposed public offering of common stock
Marrone Bio Innovations announced that it is proposing to offer shares of its common stock in an underwritten public offering. The Company expects to grant underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock. April 24, 2017